Malignant Thyroid Gland Neoplasm — Trials

Malignant Thyroid Gland Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

790 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 176
Recruiting: 92
Ph III recruiting: 12
Growth YoY: +4.9%
Industry share: 13%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 25.9%
Trials / 1,000 deaths: 81.9 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (65)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07704658	Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors	recruiting	Phase 4	12	Rigel PharmaceuticalsINDUSTRY	1	Aug 10, 2026	clinicaltrials
NCT07600580	The Association Between Bilateral Intermediate Cervical Plexus Block During Total Thyroidectomy and Surgical Stress Response	recruiting	Phase 4	48	University Hospital DubravaOTHER	1	Jun 16, 2026	clinicaltrials